1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol

insulin ; Homo sapiens







3 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35067495 Effects of luseogliflozin on the secretion of islet hormones and incretins in patients with type 2 diabetes. 2022 Jan 22 1
2 34119556 Changes in urinary glucose concentration and body weight in patients treated with the selective SGLT2 inhibitor luseogliflozin. 2021 Dec 1
3 29448833 Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period. 2018 Jun 1